Adipogen/anti-TLR7 (human), mAb (ABM2C27)/AG-20T-0306-C100/100 µg
More Information Product Details
Synonyms Toll-like Receptor 7 |
Product Type Monoclonal Antibody |
Properties
Clone ABM2C27 |
Isotype Mouse IgG1κ |
Immunogen/Antigen Recombinant human TLR7 protein (aa 500-900). |
Application Flow Cytometry: (0.5μg/106 cells)Immunohistochemistry: (5μg/ml; paraffin sections)Western Blot: (2-4μg/ml)Optimal conditions must be determined individually for each application. |
Crossreactivity Human |
Specificity Recognizes human TLR7. |
Purity Protein G purified. |
Concentration 0.5mg/ml |
Formulation Liquid. In PBS containing 0.05% BSA and 0.05% sodium azide. |
Accession Number Q9NYK1 |
Shipping and Handling
Shipping BLUE ICE |
Short Term Storage +4°C |
Long Term Storage -20°C |
Handling Advice After opening, prepare aliquots and store at -20°C.Avoid freeze/thaw cycles. |
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.Stable for at least 6 months after receipt when stored at +4°C. |
Documents
MSDS No |
Product Specification Sheet
Datasheet Download PDF |
TLR7 (Toll-like Receptor 7) is a member of the TLR (Toll-like receptor) family that plays a fundamental role in pathogen recognition and activation of innate immunity. TLR7 is a nucleotide-sensing TLR. TLR7 and TLR8 recognize single-stranded RNA (ssRNA) sequences containing GU-rich or poly-U sequences as their natural ligands, and they are also activated by synthetic small-molecular-weight compounds of the imidazoquinoline family. Both TLR7 and TLR8 signal via MYD88 and TRAF6, leading to NF-κB and antiviral factor, such as IRF family activation, cytokine secretion and the inflammatory response. They are localized intracellularly to endosomal membranes and act as potent activators of innate immune responses upon viral infection. The TLR7 gene is predominantly expressed in lung, placenta and spleen, and lies in close proximity to TLR8 on chromosome X. TLR7 has been shown to play a significant role in the pathogenesis of autoimmune disorders such as Systemic Lupus Erythematosus (SLE) as well as in the regulation of antiviral immunity. Recently, small molecule TLR7/8 agonists have demonstrated potential as vaccine adjuvants, since they directly activate APCs and can enhance both humoral and cellular immune responses, especially Th1 responses. This makes the TLR7/8 signaling pathways interesting therapeutic targets.
本文链接: https://www.ebiomall.cn/b585-abm/info-1531115113.html
免责声明 本文仅代表作者个人观点,与本网无关。其创作性以及文中陈述文字和内容未经本站证实,对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不做任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
版权声明 未经蚂蚁淘授权不得转载、摘编或利用其他方式使用上述作品。已经经本网授权使用作品的,应该授权范围内使用,并注明“来源:蚂蚁淘”。违反上述声明者,本网将追究其相关法律责任。